We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/1/2021 11:12 | Queit before the storm, these guys always go very quiet when working on something | alphabravo321 | |
26/1/2021 12:54 | Full year 2020 results - 4th March. | moorsie2 | |
26/1/2021 08:05 | I agree, you could be forgiven for thinking that someone at some point my realise the value here and try to buy the company | alphabravo321 | |
26/1/2021 07:48 | Quarterly results early Feb perhaps? Just scan read the news announcements over the last 12-18 months and I’m a little surprised that we’re not moving ahead in terms of share price. AMRYT seem not to be putting a foot wrong with the business growing very nicely indeed. | bazworth | |
21/1/2021 09:08 | Yep I have tried that a few times, it would be easier to get in touch with Biden! | alphabravo321 | |
21/1/2021 09:06 | I would suggest you contact IG directly. I use iii and all three of the rights are clearly shown Good luck! | bazworth | |
21/1/2021 08:30 | Anyone figure out how to get CVRS showing on an IG account? | alphabravo321 | |
20/1/2021 23:09 | free stock charts from uk.advfn.com | papillon | |
20/1/2021 23:08 | The chart trend of AMYT is most definitely upwards | papillon | |
20/1/2021 22:40 | "I expect the first cash to come in this year." That would be very nice, sidam. I hope you are correct! | papillon | |
20/1/2021 22:33 | My CVRs are still shown as a holding in my ISA. I am certainly not going to rock the boat by asking if that is OK. I expect the first cash to come in this year. | sidam | |
20/1/2021 19:27 | Stock has been hard to get. Would expect significant rises in the coming days | moorsie2 | |
20/1/2021 17:56 | More big trades coming through | alphabravo321 | |
20/1/2021 16:38 | Might be right. I hold in a SIPP but the rules are different to ISA's | waterloo01 | |
20/1/2021 16:26 | Yep that's my understanding too but don't think CVRs can be held in an ISA. | bermudashorts | |
20/1/2021 16:08 | thanksIR didn't reply to my email and couldn't find anything on web | richman777114 | |
20/1/2021 15:53 | richman, yes my understanding as well unless held in a tax wrapper (ISA etc). | waterloo01 | |
20/1/2021 15:46 | Currently, only 11.3 mg vials (10 mg dose) metreleptin are available at a list price of £2,335 per vial. The availability of smaller vial sizes is expected within three months of submission of the variation to marketing authorisation, at a list price of £1,167.50 for a 5.8 mg vial (5 mg dose) and £583.80 for a 3 mg vial (2.5 mg dose). Based on the distribution (11.54% 10 mg dose; 69.23% 5 mg dose; 19.23% 2.5 mg dose) of observed current doses in the UK early access programme (EAP), an average annual per patient price of £434,633 is assumed in the analysis. Due to a loss of drug exclusivity after 10 years, a decrease of 90% of the list price of metreleptin was assumed in the model in one of the scenario analyses. hxxps://www.nice.org hxxps://www.engage.e ==== there's around 70 people in the uk suffering from this illness potential yearly revenue : over £50m | delta0091 | |
20/1/2021 15:34 | hello,does anyone know the tax treatment re the CVRs?my assumption is that the issue of them was not a taxable event vis a vis shareholders and that any cash received following the achievement of milestones is subject to cgt with a nil base cost | richman777114 | |
20/1/2021 15:25 | Andra Stratton @livinlavidalopo ยท 1h OMG! This is THE BEST NEWS!!! I am in tears of joy for my #lipodystrophy family in UK. @LDUK was relentless in their efforts to unite stakeholders and get this result. Patients for the win again! Bravo @Becky_Sanders_ #PatientAdvocacy | delta0091 | |
20/1/2021 15:24 | the sheer joy of this lady, regarding today's news, is inspiring | delta0091 | |
20/1/2021 14:19 | USA will help this share. UK investors need a kick. | babbler | |
20/1/2021 14:01 | Strange the number of shares bought at 1235 is exactly 5 times the first trade on Nasdaq of 69054 | alphabravo321 | |
20/1/2021 13:20 | the best kind! | waterloo01 | |
20/1/2021 13:19 | Delayed gratification... | cwa1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions